Introduction
Thirty-five years of medical practice have convinced
me that all vaccines carry an important risk of chronic disease
that is inherent in the vaccination process and indeed central
to how they work. Yet the growing concerns of parents and legislators
and media reports about them rarely if ever elicit anything
beyond automatic denials by medical and public health authorities
alike. Reflecting on this glaring discrepancy is the main focus
of this essay. Writing these lines has also helped me appreciate
how much the invisibility heightens the risk and how intimately
these phenomena are connected, like mirror-images of the same
reality, which makes it imperative to study them together.
Since I am mainly a clinician, I will begin with a story.
It concerns a 12-year-old boy whom I know of solely from his
mother’s letter, but her words are so heartfelt and so congruent
with the rest of my experience that I cannot doubt their veracity:
“My son Adam was healthy until his first MMR at 15 months. Within
2 weeks he had flu and cold symptoms, which persisted for 6
weeks, his eyes became puffy, and he was hospitalized with “focal
sclerosing glomerulonephritis,” but he didn’t respond to steroids.
I asked if it could be related to the vaccine, but they told
me it couldn’t, and we accepted that. Over the next 4 years
he was hospitalized repeatedly but then went into remission,
seeming normal and healthy and staying off all medications for
5 years.
When he turned 10, his pediatrician recommended a booster,
saying that a rise in measles cases made it dangerous for him
not to be protected. I checked the PDR and other sources but
found no warning for kidney disease and no listing of it as
an adverse reaction, so I agreed to it. In less than 2 weeks
he relapsed, with 4+ proteinuria, swelling, and weight gain,
signs that we recognized immediately. He was admitted in hypertensive
crisis, with blood in the urine, fluid in the lungs, and massive
weight gain. On Cytoxan, massive doses of Prednisone, and three
other drugs he slowly improved, but missed another 7 months
of school.
It’s been 2 years since that horrible episode, and he still
needs Captopril for high blood pressure and spills 4+ protein
every day. The doctor says he sustained major kidney damage,
will always need medication to control his blood pressure, and
will worsen as he grows, necessitating a transplant eventually.
This time I was convinced that his condition was related to
the vaccine, but still the doctors didn’t take me seriously
and told me it was a coincidence.
I searched for information and even contacted the manufacturer
of the vaccine. Finally they sent me two case reports of neprhotic
syndrome. It’s very difficult for lay people to get information
or even ask questions, since we don’t use correct medical terms
and feel stupid. Please tell me if my ideas are reasonable.
I don’t think my son could tolerate another episode, and I think
he’d have normal blood pressure and kidney function if not for
that second shot.
I also have great concern for other children who develop nephrotic
syndrome some weeks after receiving MMR and whose doctors never
make the connection. They could all be at great risk if revaccinated.
I realize that this letter has taken up a lot of your time,
and I’d appreciate any help you can give me. Thank you.1”
Like many others who seek my help, this woman honestly
believed that her son had been crippled for life by the MMR
vaccine, yet had no intention of suing the drug company who
manufactured it, the doctors who administered it, or the government’s
Vaccine Injury Compensation program, as she was entitled to
do. Whether she didn’t think she could win, a conclusion my
experience would certainly justify, or simply was not a litigious
person, as seems more relevant in her case, the absence of such
motive only lends further credence to her story. She was writing
to me simply to find a physician to hear and validate the truth
of her experience, which neither the pediatrician who gave the
shots, nor the specialists who treated Adam in the hospital,
nor any of the other doctors she spoke to were willing to do.
Although I had very little else to offer her, it was more than
enough to earn her gratitude.
To those inclined to discredit such tales, I reply that the
confidences our patients entrust to us represent the truth as
they live it. Yet when vaccines are involved, such stories are
routinely dismissed out of hand, as if they couldn’t possibly
be true or worthy of serious consideration. That was the reaction
of every doctor involved in Adam’s care, despite compelling
evidence to the contrary, even after case reports were supplied
by the drug company itself. Whether a canny strategy to defeat
possible litigation or simply the instinctive shielding of a
cherished world-view from threat of change, this defensive and
hostile stance is so pervasive in the medical profession as
to merit careful study in itself.
Richard Horton, Editor of The Lancet, felt the sting of censorship
himself after publishing an article linking cases of infantile
autism and colitis to the MMR vaccine:
Today vaccines are largely an untouchable subject, their benefits
too obvious to be questioned. Any hint of dissent concerning
their clinical effectiveness and overall social value is met
with bitter rebuttal and resentment. A former President of the
UK Academy of Medical Science actually threatened to get me
sacked for publishing work that raised questions about the MMR
vaccine, while at a dinner party years later, the partner of
a government vaccine specialist asked, “Will you ever
be forgiven?” Forgiven for what, I wondered?2
Dr. Horton himself neither believed in the research nor endorsed
its conclusions. His only “mistake,” if mistake it was, lay
in permitting the author, a well-known British gastroenterologist,
to publish his findings without regard for their political correctness.
Needless to say, the snubs and threats he faced for rocking
the boat were less serious than the reprisals exacted against
the author, whose work was officially repudiated without testing
it, and whose career at a London teaching hospital was abruptly
terminated.3
Finally, Adam’s misfortune obliges us to ask how “glomerulonephritis,”
“autism,” “encephalopathy,” or any other disease gets to be
identified as a bona fide complication of a vaccine,
such that the victim becomes eligible to receive damages in
court. In spite of two reports of MMR nephritis documented by
the manufacturer, renal failure is still not recognized as an
adverse effect of the vaccine, an omission that undoubtedly
helped Adam’s doctors to frustrate his mother’s inquiries.
Exactly similar editing characterizes the Federal guidelines for
compensation of vaccine-injured patients, which would never
have been enacted in the first place without the repeated insistence
of their parents, and which continue to be pared down even further
by the determined opposition of the vaccine manufacturers, the
American Academy of Pediatrics, and other authoritative and
influential pro-vaccine groups.
As reflected in the official compensation guidelines, research studies
of vaccine-related injuries are limited to a few extreme reactions
to particular vaccines, because these alone occur often enough
to attain statistical significance in large populations. Such
a policy automatically disqualifies two much larger and partly
overlapping classes of phenomena that my own research has uncovered:
1) exacerbation of the ordinary chronic diseases of childhood,
according to individual susceptibility, often representing 2)
a nonspecific effect of the vaccination process in general,
for which any vaccine will do. Restricting the issue of vaccine
safety to specific effects of specific vaccines is a major reason
why the true extent of vaccine-related illness has always been
invisible and will likely remain so until the question is reframed
in a more comprehensive way.
An equally troubling problem with the approved list of vaccine-related
injuries is their restriction in time to acute events
occurring within a few days afterward,4 i. e., soon
enough for the vaccine to be regarded as the necessary and sufficient
cause of the reaction, as if independently of any prior susceptibility.
In Adam’s case as in many others, vague, nondescript symptoms
appeared soon after vaccination, but the full picture of nephritis
did not emerge and could not be diagnosed until six weeks after
the first shot and two weeks after the second, by which time
it was no longer an acute or fixed injury, but already a chronic,
self-sustaining illness that has continued to develop
and worsen over the years, so that a claim on his behalf would
undoubtedly have been rejected even if it had been filed.
In what follows I will consider five aspects of the vaccine issue:
1) specific effects of specific vaccines, as described in the
literature; 2) nonspecific effects of the vaccination process,
based on cases from my own practice; 3) how vaccines actually
work; 4) several individual vaccines; and 5) implications for
vaccine and health policy.
1. Specific Effects of Specific Vaccines
The vaccination literature contains no mention of adverse
effects of the process itself, but only a few documented effects
of specific vaccines, such as encephalopathy, autism, anaphylaxis,
and so forth, most still hotly contested by authorities in the
field. Even those officially recognized as legitimate grounds
for compensation under the Federal guidelines are actually vague,
generic terms that are applicable to more than one vaccine.
Anaphylaxis, for example, is compensable not only for DPT and
its components but also for MMR, and will undoubtedly implicate
some or all of the newer vaccines in the future.
DPT Encephalopathy
This all-purpose diagnostic category was the first adverse
reaction to be identified and made compensable under the Vaccine
Injury Compensation Act of 1986, which it also helped bring
about, and is by far the most extensively documented. Here is
the story of a 3-year-old girl whose mother wrote to me for
support of her mother’s pending litigation against the child’s
doctors and the Canadian government:
Our daughter was damaged by her 18-month vaccination, which consisted
of the DPT, HiB, and oral polio vaccines. One week later she
had a bizarre screaming episode, and is now labeled “autistic.”
An MRI showed brain inflammation and demyelination. She had
25 words at 18 months and was ahead in some develop- mental
milestones as well as being quite social. After her screaming
episode she stopped talking, ignored the neighborhood kids,
made no eye contact, and develop- ed hand-flapping and other
repetitive behaviors. Her pediatrician agreed that she was autistic,
and we told the specialist that she changed abruptly after the
vaccine, and showed him a video of her as an infant and toddler,
in which she seemed total- ly normal. From photos taken before
and after, the damage is obvious: her eyes have lost their gleam,
and she looks sad and alone, but the doctors dismissed it as
a coincidence, and no mention of any vaccine was ever included
in their reports.5
Leaving aside the extremity of her misfortune and the refusal
of her doctors to accept any responsibility for it, I call attention
to her diagnoses, chiefly “encephalopathy,” a synonym
for “brain damage,” and the equally vague term “autism,” which
today is linked more commonly with the MMR vaccine. Both her
sad tale and the necessity of fixing a label to it indicate
that these are merely broad, generic, and often interchangeable
categories, referring to conditions that can result from several
different vaccines, rather than being characteristic of any
particular one.
Here is another case, from the lawyer who represented him,
a 3-year-old boy who reacted badly to his first DPT and suffered
permanent brain damage after the second:
Our firm represents a child who was born normal and healthy
in every way. After the first DPT at 6 weeks, he began falling
off growth charts, exhibited multiple developmental delays,
and was diagnosed as “failure to thrive,” but then slowly began
to recover. At 5 months he received a second DPT, and his delays
became much more extreme. He has never recovered. He is now
3 years old, with the mental capacity of an infant of a year
and a half. I am convinced that his problems came about as a
result of the DPT. In view of what happened after the first
shot, he should not have had the second, or at least the Pertussis
component of it.6
This tragic pattern of a warning ignored, of a lesser version
of the same illness with eventual recovery, followed by death
or irreversible brain damage after a repeat vaccination, formed
a major subtext of the expose DPT: A Shot in the Dark,
in which medical historian Harris Coulter and Barbara Loe Fisher,
the mother of such a child, collected the stories of over 100
little victims.7 The outcry over DPT encouraged
Ms. Fisher and a friend to found the National Vaccine Information
Center, a support and advocacy group for families and friends
of vaccine-injured children.
NVIC still hosts conferences, provides educational materials,
and maintains a data-base and network of local chapters all
over the country. It has kept vaccine issues in the public eye,
lobbied and testified before Congress, and helped to write the
Vaccine Injury Compensation Act of 1986, which created a program
for no-fault compensation of vaccine injuries as an alternative
to litigation. Yet Coulter and Fisher’s book was withdrawn by
the publisher soon after its release, while an influential group
of pediatricians still refuses to accept even these most egregious
cases as having any connection with the vaccine. In 1990, Dr.
Edward Mortimer et al. published a review in the Journal
of the AMA which claimed that “No child who was previously
normal without a prior history of seizures had a seizure in
the three days following a DPT vaccine that marked the onset
of epilepsy or other neurological or developmental abnormality.
Our negative findings reinforce those of previous investigators
that serious neurological events are rarely if ever caused by
DPT.8”
In the lead editorial of the same issue, Dr. James
Cherry, another leading advocate, cited these data as conclusive
proof that DPT encephalopathy is a “myth,” or coincidence, which
should be erased once and for all from the ever-shrinking list
of “genuine” adverse reactions providing an acceptable basis
for compensation:
“In recent months three controlled studies examine the risk of seizures
and other acute neurological illnesses after DPT, involving
230,000 children and 713,000 vaccinations. These studies found
no evidence of a causal link between the DPT and permanent neurological
illness. It is not surprising that physicians tended to blame
the vaccine for these events. But these recent studies show
that the major problem has been our failure to separate sequences
from consequences. It is late in the 20th century,
and it’s time for the myth of “DPT encephalopathy” to end.9”
His words also tally closely with the official report
of the Advisory Committee on Immunization Practices, which acknowledged
the opposing claims of parents but then tied them up in a skein
of evasions, equivocations, and government bureaucratese:
“Rare but serious acute neurological illnesses, including encephalitis,
encephalo- pathy, and convulsions, have been reported following
the whole-cell DPT. The National Childhood Encephalopathy Study
provides evidence that DPT can cause encephalopathy. This occurs
rarely, but detailed follow-up indicates that children who had
a serious neurological illness after DPT were significantly
more likely than children in the control group to have chronic
CNS dysfunction 10 years later and to have been given the DPT
within 7 days of its onset.
ACIP proposed 3 possible explanations for this association: 1) the
dysfunction could have been caused by DPT; 2) the DPT could
trigger events in children with brain or metabolic abnormalities
who might also experience them if other stimuli such as fever
or infection are present; and 3) the DPT might cause the event
in children with underlying abnormalities that would have become
dysfunctional even without it. The data do not support any one
explanation over the others. The evidence was consistent with
a causal relationship, but insufficient to determine whether
DPT increases the overall risk 10 years later.10
But even an innate predisposition to develop such
complications by no means ex-cludes the possibility of a vaccine
reaction, since all illness requires both external morbid influences
and an individual receptive to them. This is the ultimate riddle
of all medical practice, which the emphasis on specific effects
for specific vaccines blithely glosses over.
It is obvious to me and to most parents that a family history
of serious adverse reactions, especially in parents or siblings,
places children in a much higher risk pool and therefore provides
valid grounds for exempting them from vaccinations. Yet even
affidavits from Board-certified pediatricians don’t always suffice:
I am writing about our 3-year-old son, for whom we seek medical
exemption from the DPT, MMR, and HiB. Two older siblings had
severe reactions to these shots, with fever of 105, sleeplessness,
and swelling at the injection site. Until age 6 both kids had
recurrent ear infections, for which tonsillectomy was proposed,
while our youngest has not been immunized, and has no ear infections.
We tried oral polio vaccine as an infant, which was followed
by extreme irritability and insomnia that lasted for weeks.
6 months ago we repeated it, with the same result. Our pediatrician
has written that he is at high risk for reacting adversely,
but the judge ignored her. By State law, a letter from a licensed
doctor stating medical reasons why he should not be vaccinated
is sufficient. But the city guidelines give the Health Department
final say, so we’ve ended up in court.11
Before their hearing, the mother obtained a second letter from
another pediatrician, which the City Health Department similarly
rejected:
The family history indicates epilepsy in the father and extensive
allergies in the mother. The child displays a pattern of nervous
system hyperactivity in response to foods, and was also sick
for weeks after oral polio both as an infant and again recently.
I strongly recommend against any further immunizations for this
child, the risks of which outweigh any potential benefits for
him or the general public.12
Since my testimony was never required, I surmise
that the parents eventually won, but their ordeal attests to
the draconian spirit in which vaccination laws are often enforced.
DPT and SIDS
For decades the leading cause of death in infants less
than one year old, Sudden Infant Death Syndrome has always baffled
pediatricians. Yet pertinent research on SIDS continues to be
ignored in this country because its conclusions are unpalatable
to the small coterie of doctors who conduct vaccine research,
journal editors who publish it, and manufacturers who fund it.
In 1985, Dr. Viera Scheibner, a research scientist investigating
SIDS in Australia, and Leif Karlsson, an engineer, developed
an electronic monitor that made it possible to follow breathing
patterns of young infants from an adjoining room.13 Designed
to sound the alarm if breathing fell below a minimum rate or
amplitude, the device immediately produced surprising results:
Soon parents were reporting alarms while their babies were
deeply asleep, often in clusters of 5 to 7 within a 15-minute
period. These occurred after the babies were exposed to stress,
or a day or before they developed a cold or cut a tooth. In
most cases, the babies were only breathing shallowly and soon
resumed normal patterns Without intending to, we also noted
their breathing before and after vaccination, and the results
were extremely significant. We didn’t know that its merits were
being hotly debated at the time. We saw flare-ups of shallow
breathing or apnea for 45-60 days after the DPT. When we showed
our findings to pediatricians, they pointed to the arrow when
the shot was given, saying “This is the cause!” and to the abnormal
breathing pattern, saying “This is the effect!” But when we
told them our interpretation of these data, we realized we’d
touched on a very sensitive area.14
In Australia the medical community greeted these
findings with a stony silence, which continues to this day,
while the American literature has never published a single study
to try to validate or refute it. An equally wet blanket has
been thrown over the few epidemiological studies connecting
SIDS to the vaccine. In 1979 the Tennessee Health Department
reported 4 cases occurring within 24 hours of the first DPT,15
while in a study of 70 cases prompted by them, Dr. William Torch
found that 6.5% occurred in less than 12 hours after a DPT shot,
13% within 24 hours, 26% within 3 days, 37% within 7 days, 61%
within 14 days, and 70% within 21 days.16 He concluded,
DPT may be a major unrecognized cause of sudden infant death,
and the risks may outweigh the benefits. Re-evaluation and possible
modification of current policy is indicated by this study.17
Further confirmation came from Japan, where 57 encephalopathic
cases and 37 deaths between 1970 and 1974, followed by two dramatic
SIDS deaths in 1975, raised a storm of protest that persuaded
the government to postpone all DPT vaccinations until two years
of age,18 and to promote the development of a safer
acellular vaccine. As Dr. Cherry and his colleagues later conceded,
the result of this policy was that “SIDS disappeared when whole-cell
and acellular pertussis vaccinations were delayed until 24 months
of age.”19 Yet these same experts never contemplated
such a strategy for our own country, even when the acellular
vaccine failed to lower the risk of brain damage to an appreciable
extent.20 Today the United States is the only industrialized
country that requires the DPT vaccine for all young infants,
despite all the evidence against it and the nearly unanimous
opinion of Western European, Japanese, and other foreign medical
sources.
MMR and Autism
First described by the American psychiatrist Leo Kanner
in 1943, the neurological condition he called “autism” has never
been satisfactorily explained. Just as it could have been mere
coincidence that his first case appeared very soon after the
DPT vaccine was introduced in 1942, no strong evidence for a
vaccine link emerged until the late 1990’s. In 1995 Dr. Andrew
Wakefield, a British gastroenterologist, compared 3550 adults
vaccinated against the measles as infants, with 11,400 peers
who had not been, and found that the vaccinated group were three
times more likely than their unvaccinated controls to develop
Crohn’s disease later in life, and twice more likely to develop
ulcerative colitis.21
These oddities led Wakefield to study children who reacted adversely
to the MMR, many of whom developed normally during the first
year but then regressed to an autistic state following the vaccine,
suffered from digestive symptoms and food and environment-al
allergies, or both.22 Detailed comparison of these
children with age-matched controls revealed inflammatory lesions
in the small intestines of autistic children that microscopic-ally
resembled those of Crohn’s disease and ulcerative colitis; circulating
antibodies in the blood of the autistic children that were specific
to measles, but not to mumps and rubella, the other MMR components;
measles antigens in the lymphoid aggregations of the small intestine,
but none from mumps or rubella; and no antigens of any kind
in the intestines of normal children.23
These findings have since been replicated by Japanese investigators,24
and the identical combination of autistic symptoms, enterocolitis,
and food and environmental allergies following MMR vaccination
has been reported by parents in the US, the UK, Canada, Australia,
Western Europe, and parts of Asia.25 Further support
for Wakefield’s MMR hypothesis has come from the circumstance
that the UK, which uses the same diagnostic criteria for autism
as we do, experienced a similarly dramatic increase in autism
cases at the time when the MMR was introduced in Britain,26
and from the experience of holistic physicians in Europe and
America that alleviating the food and environmental allergies
is proportionately beneficial for the autistic symptoms
as well.27
Yet no proof has ever convinced the pro-vaccination forces,
who maintain a seem-ingly unbreakable stranglehold over American
health policy. A few years ago, Rep. Dan Burton chaired Congressional
hearings on the issue when his grandson became seriously ill
after his MMR and was diagnosed with autism. Disregarding the
NIH’s own estimate of the incidence of autism at about 1 in
500 in 1996, an increase of over 400% since the 1960’s,28
Dr. Colleen Boyle of the CDC reaffirmed the official line that
“current scientific evidence does not support a link between
vaccination and autism or any other behavior disorder.”29
Similar denials by Dr. Paul Offit of ACIP led Burton to respond
that Offit’s consultations for Merck, the vaccine manufacturer,
amounted to a conflict of interest that should have disqualified
him from serving on the Committee:
Even if they exclude themselves from voting, people who sit
on advisory panels and are paid by pharmaceutical companies,
influence other members. Are we letting pharmaceutical companies
have too great an influence on decisions that affect the health
of our nation?30
Even when it is finally recognized as a bona fide complication
of MMR, “autism” as a diagnostic category is as vague as “encephalopathy,”
is also applicable to DPT cases, as we saw, and will undoubtedly
become so to Hep B, HiB, and other vaccines as well.
Hepatitis B and Auto-Immune Diseases
The official ACIP verdict on the Hep B vaccine makes it sound like
one of the safest currently available:
Hepatitis B vaccines are safe to administer to adults and children.
More than 10 million adults and 2 million infants and children
have been vaccinated in the US and over 12 million children
worldwide. Pain at the injection site and fever have been among
the most frequently reported side-effects, but no more so than
in the controls receiving placebo or DPT. The incidence of anaphylaxis
is low. Large- scale programs in Alaska, New Zealand, and Taiwan
have not established an association with other adverse events.
Any presumed risk that might be causally associated must be
balanced against the expected risk of hepatitis B liver disease.31
In my experience, however, the vaccine carries a major risk
of auto-immune dis-eases of every type, including lupus, thyroiditis,
and major blood dyscrasias, which is also confirmed by a large
volume of anecdotal case reports, and by warnings listed in
the PDR by the manufacturers themselves. As we saw, the main
value of the ACIP whitewash is to guarantee that nearly all
private lawsuits and no-fault claims will fail.
Here is a typical case from my own practice, an 18-year-old
college student who became ill soon after his second Hep B vaccination
at the age of 10:
He remained in good health and developed normally until the
age of 10, when two doses of Hep B vaccine were given, with
no ill effects from the first. A week after the second dose,
a swollen lymph node appeared in his neck, with fever, malaise,
joint pains, and other flu-like symptoms, from which he has
never fully recovered. Losing 20% of his body weight, he developed
large subcutaneous nodules near major joints, and.a very high
sedimentation rate. Diagnosing an auto-immune mixed connective-tissue
disease, a rheumatologist kept him on non-steroidal anti- inflammatory
drugs and Prednisone for 6 years, as a result of which his growth
and sexual maturation were seriously retarded. When I saw him,
he had taken no drugs for 6 months, but his face and eyes were
still swollen, his cheeks were covered by a bright-red rash,
and his muscular and sexual development were those of a puny
12-year-old. Over the past two years, he has improved a lot
under homeopathic treatment, but continues to be chronically
ill, seriously handicapped, and likely to remain so. His parents
are certain that Hep B vaccine was the main cause of his illness,
but his medical records contain no written statement to that
effect.32
Here are two claims of Hep B vaccine injury whose medical records
I have studied thoroughly enough to write detailed reports to
the hearing officer. While quite different in the organs and
tissues affected, they resemble each other in their overall
flavor and style.
An adolescent girl with type 1 juvenile diabetes was in good health
and stable condition before receiving the vaccine. Within a
few days of her first dose, she developed fatigue and malaise,
itched intensely from hives all over her body, and her skin
grew puffy and swollen. In a few weeks she developed joint pains,
and the hives made her scratch to the point of bleeding. Medications
gave temporary relief. Her high sed rate and anti-nuclear antibody
titer indicated an auto-immune illness resembling lupus, but
vigorous treatment did not help, and she developed allergic
reactions to chemicals and food additives that had not bothered
her before, while her diabetes, which had been stable for years,
went seriously out of control.
After several months her mother broke off the treatment, saying,
“Before the shot she was active, full of life, and not allergic
to anything. Now she has to analyze everything she eats, avoids
the sun, and has to take EpiPen wherever she goes. She is allergic
to preservatives and food colorings, but has no idea what else
will trigger hives and rashes.” After 4 years, her claim is
still pending.33
A previously healthy 31-year-old lab tech developed
auto-immune thyroiditis soon after her second round of Hep B
vaccinations. At 24 her doctor gave her two shots two months
apart, as required for her training. 3 months after the second
dose, she developed a cough that lasted for weeks and cleared
up on antibiotics, after which she took the third dose. With
no antibody titer 4 years later, she was thought to be still
susceptible to the disease, so her new employer insisted that
she be receive a second round. Within a few days after the first
dose, she developed a sore throat and cold symptoms, followed
by weakness, fatigue, hoarseness, and weight gain that persisted
for months. She took a second dose and grew much worse, with
a more intense version of the cough she had had before, causing
palpitations and anxiety at night. Finding her TSH to be twice
normal, her doctor gave her thyroid, followed by her third dose
of Hep B, and her symptoms and elevated TSH lasted for months
with no improvement. Even after thyroid antibodies were found,
she continued to worsen, despite ever-higher doses of hormone
and normal tests. She has since developed a nodular goiter,
difficulty swallowing, and esophageal reflux. In short, this
previously healthy young woman will remain chronically ill for
the rest of her life, needing regular supervision and strong
medication. The most clear- cut of any that I’ve reviewed, her
claim was dismissed without a hearing, based on current Federal
guidelines.34
These cases are also recognizably similar to other reports
of auto-immune diseases from Hep B vaccination in the literature,
e. g., cryoglobulinemia,35 lupus and rheumatoid arthritis,36
Guillain-BarrÈ syndrome,37 optic neuritis and MS,38
chronic fatigue syndrome,39 vasculitis,40
and diabetes.41 As with the DPT and MMR, many of
the same old diagnoses, such as seizures, autism, and demyelinating
diseases, keep popping up after Hep B as well. As I will presently
show, the term “auto-immune disease” encompasses the whole gamut
of non-specific reactions to the vaccination process per
se. As for SIDS, it could follow any vaccine given
early enough, especially Hep B, which is given soon after birth,
as this father learned too late to save his newborn son:
For 12 days, Nicholas ate and slept well, like any other baby.
On the 13th day he was given Hep B. When I got home
from work, he was crying a lot more than usual, even screaming
at times, but we’d just taken him for a checkup and they told
us he was big and healthy. We didn’t know that vaccines can
cause problems. Nicholas cried on and off most of the night.
When I went to work the next day, he was still crying, and he
continued most of the day and evening. The next morning my wife
found him dead in his crib, looking as if he’d been dead for
several hours. An autopsy showed that Nicholas had died of SIDS.
The pediatrician said he was one of the healthiest babies he’d
ever seen.42
2. Nonspecific Effects of the Vaccination Process in General
Having questioned the specificity of four well-documented
reactions to particular vaccines, around which all debate has
so far been framed, I will now consider the far more prevalent
adverse reactions that I have witnessed in my practice. For
the most part, these represent simple intensification of underlying
tendencies that were already present, and encompass the full
range of common ailments encountered in any pediatric practice,
like ear infections, eczema, asthma, and behavioral and developmental
issues. Although the details of their treatment are irrelevant,
it is significant that these children responded to the same
homeopathic or conventional medicines that would be given in
such cases, whether vaccinated or not. From these strange circumstances,
I conclude that the small number of adverse reactions reported
in the literature make up no more than the tip of an enormous
iceberg, the remainder of which lies hidden, unseen, and invisible,
because it blends into the mainstream of clinical medicine,
and because vaccines play a major but by no means exclusive
role in causing them.
Making the Connection: Childhood Ear Infections
As we saw, causal connections between vaccines and chronic illness
are obscured by the usual time lag of two weeks before their
symptoms become diagnosable. Parents and doctors are equally
unlikely to suspect a vaccine if the illness is an aggravated
version of what the child already has or what friends and classmates
are also coming down with.
My first definite cases were specific reactions that I managed
to identify from characteristic signs of a particular vaccine
or component, and at times to confirm by the curative effect
of homeopathic medicines prepared from the natural disease.
In one such case, I noticed that in addition to its specific
action on the parotid gland and the posterior auricular lymph
nodes, the MMR also had a nonspecific effect on the immune system
as a whole, making the boy more susceptible to other ailments
going around the neighborhood:
I saw a 4-year-old boy for bilateral soreness and enlargement
of the posterior auricular nodes for the previous year, when
he also became more prone to upper- respiratory infections.
Over the same period, his mother also noticed recurrent swelling
of the parotids, beginning soon after his MMR vaccine at the
age of three. Because she was pregnant, I decided not to treat
him until after the birth. A year later, he developed acute
bronchitis, and again the nodes were swollen and tender, so
I gave him the homeopathic rubella vaccine. The cough soon subsided,
and the nodes regressed in size. Two weeks later he returned
with a hard, tender swelling in the cheek and pain on chewing
or opening the mouth. After one dose of homeo- pathic mumps
vaccine, these symptoms also subsided, and he remained well.43
As in other cases, the specific reaction to a vaccine helped
me recognize it, but the reaction as a whole was vague and nondescript,
suggesting an underlying tendency that most children do not
have. The rapidly increasing prevalence of childhood ear infections
during those years soon taught me that such nonspecific reactions
are the rule rather than the exception, and provided a large
body of evidence that was ready to hand. Here is a typical example,
a 19-month-old girl whose MMR vaccination was soon followed
by ear infections and a flare-up of allergies and eczema, which
she had had only mildly before:
At 19 months of age she had already suffered 5 ear infections
and 5 rounds of anti- biotics since her MMR 4 months earlier,
with eczema and allergic rhinitis as well. Although her allergies
began soon after birth, they were mild, while the eczema was
confined to a few small patches on the face. With no obvious
reaction to her DPT’s, she did fine until her MMR, after which
her ears flared up repeatedly, often with high fever, earache,
and listless, clingy behavior, and never cleared up despite
5 rounds of antibiotics, while her allergies became intense
and unrelenting, and the eczema spread over her entire body.
Advising them not to use antibiotics if she got sick and not
to vaccinate for a while, I gave her homeopathic medicine, and
the ears healed promptly, but her eczema and nasal congestion
took a bit longer. Now 12, she has had no more shots, and enjoys
excellent health and normal hearing.44
Occasioned by the MMR more than the DPT or other vaccines,
and not included on any official list, this girl’s reaction
consisted of ear infections, one of the commonest illnesses
of her age group, as well as a recurrence and intensification
of the same allergies and eczema she had had in the past. Here
is another typical variant, a girl of 15 months who had had
11 ear infections and 11 full courses of antibiotics by the
time I first saw her:
Otherwise in good health, a chubby girl of 15 months was brought
in for recurrent ear infections, which had never cleared up
despite 11 rounds of antibiotics. After a healthy pregnancy
and labor, her mother didn’t nurse, and her first ear infection
came with a fever of 103_ at 2 months of age, soon after her
first DPT, HiB, and polio. All later episodes were afebrile,
with fretting, screaming, and pulling the ear, and were relieved
by being carried about. Twice she seemed fine, but her doctor
found some fluid.
Asking the parents to stop vaccinating her, I gave homeopathic medicines,
and in 2 weeks she developed a replica of her first episode,
with fever of 102_ and intense screaming. She came through it
in a day or so and has been entirely well since, once catching
a cold without ear involvement for the first time. By then she
was thriving, growing, and gaining weight, with good appetite,
sleep, and energy. That was 3 years ago. Since then she’s had
no ear infections and no vaccines.45
In spite of the clear link between her first episode
and the combined vaccines, this girl’s condition became so chronic
that later shots made no difference, except for her last episode,
which presented with fever, just like her first. From such cases
I have learned to regard acute illness as a good prognostic
sign, indicating strong vitality and an immune system that is
developing normally, and to worry about children who are unable
to mount a fever or acute response to infection, as the immune
system is programmed to do. My sense is that all vaccines, whatever
their specific effects, tend to reprogram the organism to react
more chronically in general, whatever the illness, as shown
by my next case, a girl with recurrent ear infections of the
same type following several different vaccines:
A baby girl of 10 months was brought in for otitis media with
high fever, intense earache, and loud screaming, her 5th episode
since two months of age, each begin- ning soon after finishing
the antibiotic from the one before. The cycle began when her
mother weaned her to go back to work, she became fussy, and
she developed a rash on milk-based formula. All symptoms were
intensified after her first DPT, HiB, and polio, culminating
two weeks later with high fever and violent earache, as with
all later episodes. After that, she was given the DT, which
she didn’t react to in any way, except that her ear infections
continued as before.
With homeopathic medicines, they stopped soon enough, but came
back with a vengeance when her parents separated 6 months later,
and her father insisted on taking her for the MMR. 3 acute ear
infections and 3 rounds of antibiotics follow- ed in rapid succession.
Again she responded well to homeopathic treatment, and remained
in very good health overall, despite a tendency to relapse whenever
she visited her father, who indulged her with dairy and took
her to the doctor for her quota of vaccines and antibiotics.
Now a freshman in college, she still gets sick at times, but
her ear infections are gone, and her robust immune system has
helped her respond acutely and vigorously and recover quickly.46
This girl’s almost identical reaction to two different vaccines indicated
a definite predisposition to fall ill in a certain way that
was recognizably her own and already in place when the vaccines
were given, the important and obvious contribution of vaccines
being simply to reactivate and intensify it.
Making Worse What’s Already There: the Common Diseases of Childhood
From this viewpoint, I began to notice a similar causal link
between childhood vaccines and the usual chronic illnesses,
such as asthma, eczema, sinusitis, behavioral problems, and
the like. As with ear infections, if the condition was already
symptomatic prior to vaccination, a dramatic intensification
was observed not long afterward, while if quiescent it was often
reactivated. As before, many children reacted in a similar way
to two or more different vaccines, indicating a peculiar characteristic
of the individual rather than a specific effect of the vaccine,
and often linked with a family history or past history of the
same kind. At times the reaction occurred too long afterward
for anyone to suspect a vaccine until the same pattern was observed
from a later dose or a different vaccine.
Moreover, these reactions likewise encompassed the usual range
of ailments seen in any pediatric practice, vaccinated or not,
and were curable by the same group of medicines, homeopathic
or not. Unlike the specific effects of specific vaccines, which
are narrowly defined to be as serious and as rare as possible,
these nonspecific reactions are common enough to be the rule,
not the exception, though by no means necessarily minor or trivial:
A 15-month-old boy was brought in for croup, recurrent colds,
swollen glands, and developmental issues. Born to a diabetic
mother, he weighed 8 pounds at birth and spent weeks on a respirator
in the Newborn ICU because of “undeveloped lungs,” with cyanosis
and unstable blood sugars. In the early months he was colicky
and had a severe diarrhea that stopped when his mother eliminated
wheat from her diet. At 3 months, soon after his first DPT,
HiB, and polio, he became very rest- less, with swollen glands
and a sickly pallor that lasted for months and culminated in
a prolonged attack of croup, high fever, and sunken chest that
required hospital- ization and IV corticosteroids for relief.
When the cough persisted, his mother put off the second round
of shots for months, but even so the croupy cough came right
back, as did the swollen glands and exactly the same symptoms
as before. With a marked fear of strangers, the boy appeared
subnormal, drooling profusely with his mouth hanging open, and
hiding behind his mother. Once I found a good homeo- pathic
medicine that fit his symptom-picture, the illness cleared up
in a few days and never came back. A month later, his mother
was ecstatic. For the first time, in the dead of winter he had
no croup or swollen glands, slept well, and seemed more alert,
more interested in his surroundings, and less fearful around
strangers. That was 6 years ago, and I’ve not seen him since,
but his mother recently called to say that he is still thriving
and developing normally, “like other children his age.”47
In another case, a boy with severe asthma accomplished a sustained
remission with homeopathic treatment, but relapsed almost immediately
after a DPT booster:
Asthmatic since age two and testing positive for a broad spectrum
of allergens, a 4-year-old boy was brought in because a regimen
of bronchodilators and inhaled steroids all year round had not
pre winter, several requiring oral prednisone and antibiotics
as well. During the first 6 weeks of homeopathic treatment,
he cut his inhaled steroids by half, maintained higher peak
flows of 150 or more, and got through a cold for the first time
without developing asthma or requiring drugs. Emotionally, too,
he was calmer and less wild, even expressing remorse after a
fit of rage, which he had never done before.
The following summer, at the peak of his allergy season, he
was still doing well on half-doses of inhaler, and remained
healthy and energetic all spring and summer, with peak flows
at record levels of 160-175. That fall he got a DPT booster
before entering kindergarten and quickly came down with bronchitis,
for which he was given antibiotics, and his allergies also returned
in full force. Again he responded to the same homeopathic medicine
as before, and has continued to improve over the past 2 years,
without needing to come back or take it again.48
His mother’s narrative leaves little doubt that the DPT reactivated
and intensified his pre-existing condition, which had been in
almost total remission for many months. Although it is certainly
possible that the DPT and other vaccines may have played a role
in the origin of his asthma as well, an underlying predisposition
would have been an important contributing factor in any case.
What matters is that he was well on his way to being cured of
his asthma until a DPT booster set him back a lot and for a
long time.
Nonspecific Reactions: any Vaccine Will Do
As with ear infections, additional evidence of nonspecific reactions
was provided by children who responded in the same way to two
or more different vaccinations. The following case of environmental
sensitivity was so severe and its exacerbation by each vaccine
so obvious that the allergist recognized it and agreed to withhold
further doses:
A 2-year-old boy came in for asthma and allergies. Severely allergic
herself, his mother reluctantly agreed to the Hep B at birth
and a second dose at two weeks. After his first DPT, HiB, and
polio at two months he erupted with eczema all over his body,
which she knew had been caused by the vaccines, but the pediatrician
ridiculed the idea. After the second round, his stools became
green and watery for 6 weeks, and she weaned him, but Similac
led to apnea, cyanosis, vomiting, and giant hives everywhere.
Finding him highly sensitive to dairy, eggs, peanuts, and animals,
the allergist agreed he should not be vaccinated again, but
the family doctor insisted on an HiB booster at 18 months, and
in two weeks his asthma was back for real. When I saw him he
needed Albuterol daily, all year round. He too has responded
well to homeopathic medicines and is now rarely asthmatic, although
still avoiding vaccines and careful with animals and foods.49
3. How Vaccines Work: A Preliminary Hypothesis
In spite of their importance in medicine and public health and an
abundance of detailed knowledge about how the immune system
works, a vaccine still need satisfy only two minimal criteria
to be considered effective: 1) that the incidence of the corresponding
natural disease decline significantly after administering it,
and 2) that measurable titers of specific antibodies be found
in the serum of vaccinated individuals for extended periods
of time. These standards are analogous to those of the of the
drug industry as a whole, which expects vaccines and drugs to
act mainly as they are intended to, in that everything else
they do is relegated to the fine print as “side” effects, and
often simply forgotten. In short, the medical system does not
seek or even seem to want any broader conception of how medicines
affect the organism as a whole. In search of a more comprehensive
view, I will reflect on how we come down with and recover from
an acute disease such as the measles, and contrast it with what
happens after the corresponding vaccine is administered.
Natural Immunity: Absolute, Qualitative, and Lifelong.
With its affinity for the respiratory mucosa, the measles virus is
dispersed through the air by sneezing and coughing infected
droplets and inhaled by susceptible persons on contact with
them. For 10 to 14 days, the virus multiplies first in the tonsils,
adenoids, and accessory lymphoid tissues of the pharynx, then
in the regional lymph nodes of the head and neck, and finally
in the blood, spleen, liver, thymus, and bone marrow, the major
organs of the immune system. Throughout this prolonged “incubation”
period the patient usually feels quite well and experiences
few or no symptoms of any kind.50
With the first signs of illness, circulating antibodies are already
detectable in the blood, in concentrations roughly proportional
to the severity of the disease.51 In other words,
the illness we know as the measles is simply the concerted effort
of the immune system to clear the virus from the blood, largely
via sneezing and coughing, the same routes through which it
entered in the first place. This mighty exploit involves a general
mobilization that includes inflammation of already sensitized
tissues at the portal of entry, activation of B- and T-lymphocytes,
macrophages, and the serum complement system, and a host of
other mechanisms, of which the production of specific antibodies
is only one, which depends for its effectiveness upon its collaboration
with the system as a whole.
Such a magnificent effort leaves no doubt that coming down
with and recovering from acute illnesses of this kind are the
defining experiences in the healthy maturation of the immune
system. The immunity resulting from it is specific, to
be sure, in that those who recover from the measles will never
again be susceptible to it, no matter how many times they are
re-exposed in the future. But it is also nonspecific, in
the equally important sense of priming the system to respond
rapidly and effectively to other infections it may encounter
in the future.
The natural immunity acquired through recovering from acute diseases
represents an enormous net gain for the health of individuals
and their descendants, and thereby also of the community and
the race as a whole. The measles virus kills 20% of populations
exposed to it for the first time, and many centuries of adaptation
were required for our own ancestors to convert it into a routine
disease of childhood, such that when I caught it at the age
of six, nonspecific mechanisms were already in place to help
me recover from it with no complications or sequelÊ, an achievement
that I credit in no small part for the good health I enjoy today.
The ability to respond acutely and vigorously to infection ranks
among the most fundamental requirements of general health and
well-being, a truth so elementary that merely having to reaffirm
it will attest to how far we have strayed from a saner and more
wholesome conception of life.
Artificial or Vaccine-Induced Immunity: Relative, Partial,
and Temporary
When the live, attenuated vaccine virus is injected into the blood,
at most a brief inflammatory reaction may be noted at the injection
site, with no local sensitization at the portal of entry, no
incubation period, no acute illness, and no massive outpouring.
Like a conjuror’s trick, vaccination yields measurable titers
of specific antibodies in the blood, but without any overt illness
or inflammatory response, and without any significant improvement
in the general health of the recipients, apart from reducing
their statistical risk of developing the acute disease as we
know it.
But where the virus goes, how it persuades the immune
system to continue producing antibodies against it for years
at a time, and what price we have to pay for the counterfeit
immunity that they represent, are the questions that are seldom
if ever asked. Vaccines seem tailor-made to accomplish through
deception what the immune system seems to have evolved to prevent,
giving viruses, bacteria, and other foreign antigens free and
immediate access to the organs of the immune system without
any obvious or easy way of getting rid of them. No mere side
effect, the continuing production of specific antibodies over
the long term requires the physical presence of live viruses
and other highly antigenic substances inside the cells of the
immune system on a more or less permanent basis.
In the case of measles and the other live-virus vaccines,
excellent models already exist for imagining how this chronicity
might occur, and for predicting the pathologies that are likely
to follow from it. Many viruses are known for their capacity
to survive in latent form indefinitely within the cells of the
immune system without provoking acute disease, by attaching
their own DNA or RNA as extra particles or “episomes” to the
genome of the host cell and replicating along with it, allowing
the cell to perform its normal functions but adding instructions
for the synthesis of viral proteins as well.52
Residing as foreign elements within the cells of the host, latent
viruses of this type would automatically pose a major threat
to the immune mechanism as a whole, which is programmed to destroy
and remove them by every available means. Once viral elements
are incorporated into the genetic material of the host, such
attacks have no possible target but the infected cells themselves.
Chronic intracellular parasitism by latent viruses would appear
to insure a rich harvest of auto-immune diseases, which must
also be regarded as “healthy” in that removing the transformed
cells becomes the only way to eliminate the foreign material.
In short, my fear is that vaccinating children against measles and
other live viruses simply reprograms their immune systems to
respond chronically and weakly rather than acutely and vigorously
to other infections, and indeed to antigenic challenges of any
kind, a conclusion amply borne out by the clinical evidence
already presented of alarming and as yet unexplained increases
in the chronicity of ear infections, asthma, eczema, autism,
and other common diseases of childhood. It is dangerously misleading
and indeed the exact opposite of the truth to claim that measles
vaccine “protects” us against the disease by obliging
us to harbor the virus chronically instead, so that our immune
systems are less capable of responding acutely, not only to
the measles but to everything else as well.
If that is true, then the most major achievement of mandatory
vaccination could be to exchange a few epidemic diseases of
the past for the vastly more prevalent and less curable chronic
diseases of the present, with their suffering and disability
amortized at a high rate of interest over the patient’s lifetime.
It is difficult to imagine that most parents would accept such
a devil’s bargain if they were told the truth about it, let
alone open a real Pandora’s box of new diseases and mutations
for the future, through in vivo genetic recombination
within the cells of the race.
Vaccine Adjuvants
Made from killed bacteria, inactivated toxoids, tissue extracts,
and recombinant viruses, the non-living vaccines are also designed
to remain inside the cells of the host and continue to provoke
antibody responses over long periods of time. Though how they
do it is also poorly understood, something in their method of
preparation and preservation must promote similar long-term
carrier states within the antibody-producing cells, presumably
by conjugation with host-cell proteins, which would allow these
non-living vaccines to remain highly antigenic for as long as
possible. At least three kinds of chemical additives are implicated
in and indeed deliberately used for such purposes.
First, vaccines prepared from toxoids and cellular extracts
are precipitated onto adsorbents, usually aluminum hydroxide,
both to preserve them and to enhance their anti-genicity.53
There is reliable evidence that vaccines prepared without them
are much less toxic, as in recent studies of an aluminum-free
pertussis vaccine.54 Also used in cookware and other
products, metallic aluminum and its salts have been implicated
in a broad array of auto-immune, allergic, and neuropathologic
states, including Alzheimer’s disease and encephalopathy.55
Second, some vacci56 even in tiny amounts,57
formaldehyde is the last thing we would want injected into the
bloodstream of our children, let alone to trap already dangerous
vaccines inside them.
Third, several vaccines are sterilized, denatured, and preserved
with Thimerosal, an inorganic sulphur-mercury salt which
prevents bacterial overgrowth. Already linked to a broad range
of toxic and auto-immune reactions, from allergies to renal
failure and dementia,58 mercury salts and Thimerosal
in particular have been studied and publicized so widely in
recent years that the vaccine manufacturers themselves have
been scrambling to develop or discover alternatives to it.
Clinical and Epidemiological Studies of Vaccine Efficacy
The best evidence that vaccines really work dates from the
introduction of the Salk polio vaccine in the 1940’s and the
measles vaccine in the 1960’s, after which the dreaded polio
epidemics disappeared from the developed world, while the annual
incidence of measles plummeted from over 400,000 to less than
10,000 cases in the United States.59 Yet the disturbing
possibility that vaccines act in some other way than by producing
a genuine immunity is implicit in the circumstance that measles,
like other such diseases, has continued to break out even in
heavily vaccinated populations, while in such cases the observed
differences in incidence and severity between the vaccinated
and unvaccinated children have been much less dramatic than
expected.
In 1985, 157 cases of measles were reported in Corpus Christi and
nearby Nueces County, Texas, over a 3-month period, notwithstanding
a vaccination rate of over 99% and supposedly “immune” antibody
titers in more than 95%.60 In 1989, one Illinois
high school similarly reported 69 cases in 3 weeks despite verified
records of vaccination for 99.7% of the students.61
Although both reports oddly omitted the actual numbers of vaccinated
and unvaccinated cases, they effectively discredited the common
prejudice that unvaccinated children, assumed to be the main
reservoir of the disease, pose a threat to their vaccinated
classmates, a fear widely exploited by health departments to
shame reluctant parents into compliance. In fact these outbreaks
suggested the opposite, that the immunity conferred by the vaccine
can’t be genuine, or the unvaccinated kids would only be a threat
to themselves.
These inconvenient facts were dismissed easily enough by the
official explanation that artificial or vaccine-mediated immunity
is only partial and temporary, and wears off with increasing
age, leaving the child presumably unaffected and just as susceptible
as before. Indeed, this assumption is the main rationale for
revaccinating with “booster” doses at a later date. But other
studies indicate that this assumption is false. In 1980, when
the disease seemed to have been all but eradicated in the United
States, Dr. James Cherry, whom we’ve met before, found that
children previously vaccinated against the measles whose specific
antibody titers had fallen below supposedly immune levels responded
to a booster dose only minimally and for an unacceptably short
time:
In the booster vaccinees, there was only a modest initial rise
in titer, and after a year the level was almost back to where
it had been before the booster. In add- ition, we noted a lack
of “take” in 14 other children, most of whom had probably been
immunologically stimulated before. In short, the data suggested
that another booster dose might not have any lasting effect
on waning immunity.62
Both the outbreaks of measles in supposedly highly immune
populations and the failure of Cherry’s simple booster shot
to remain effective for a prolonged period of time cast doubt
on the conventional wisdom that immunity is a purely quantitative
variable, that the specific antibody titer accurately measures
it, and that by applying sufficient force it can be ratcheted
up more or less at will. Within a few years, when major outbreaks
like those just cited generated intense pressure to do something
about them, Cherry’s suddenly inconvenient research was discreetly
forgotten, and the MMR booster was duly mandated for all children
and remains in force to this day.63
Another suggestive finding emerged from a sustained outbreak of 235
measles cases reported in Dane County, Wisconsin, over a nine-month
period in 1986.64 In addition to the usual cases,
only 6% of whom were unvaccinated,65 the authors
identified a subset with so-called “mild measles,” consisting
of a paler rash, no fever, and minimal discomfort or systemic
involvement.66 To their surprise, they also discovered
that this syndrome was much commoner in previously vaccinated
kids without specific antibodies than in either unvaccinated
kids or those with high levels of antibody, both of whom were
more likely to develop the full-blown disease:
36 of the 37 un-vaccinated patients, or 97%, had rash illnesses
that met the CDC clinical definition of measles, but 29 of the
198 vaccinated patients, or 15%, did not, primarily because
of low-grade or absent fever. Of 122 patients with sero- confirmed
measles, 10 patients, all previously vaccinated, had no detectable
measles-specific IgM antibodies and significantly milder illness
than either vaccinated or unvaccinated patients with IgM-positive
serum.67
This paradoxical result suggested a kind of latent viral activity
that was undetected and indeed belied by routine serological
testing, echoing Dr. Wakefield’s original finding that children
receiving the MMR vaccine were much more likely to develop inflammatory
bowel disease later in life than their unvaccinated controls.
The inescapable inference is that artificial, vaccine-mediated
immunity is both counterfeit and dangerous, culminating in a
broad range of auto-immune diseases, as we have seen.
4. Some Individual Vaccines
With this as background, I will re-examine a number of individual
vaccines, all of which illustrate the basic issues that have
already been discussed, yet differ significantly in the seriousness
and impact of the corresponding natural diseases. Since I have
already written about DPT, MMR, and polio in the past,68,
69 I will focus on vaccines of more recent vintage.
HÊmophilus InfluenzÊ B (HiB)
Originally developed against outbreaks of bacterial
meningitis in infants and pre-school children in large day-care
centers, the HiB vaccine has been adapted to a broader and more
ambitious agenda in a sequence that has become typical in the
industry and raises pertinent economic and political issues
that I have referred to only in passing.
The first vaccine to be prepared against an organism that resides
in the healthy throat, HiB was directed against the B strain
of HÊmophilus influenzÊ, which has at times been associated
with serious invasive diseases, such as otitis media, sinusitis,
meningitis, pneumonia, laryngitis, epiglottitis, and endocarditis.
Since bacterial meningitis can be fatal or leave permanent brain
damage in spite of the most vigorous antibiotic treatment, the
vaccine establishment saw no downside in attempting to prevent
these outbreaks by vaccinating children of two years and older
who were being cared for in crowded public facilities. After
a small pilot project of this kind, the vaccine was eventually
mandated for all children at 18 months, and is now administered
with the DPT at 2, 4, 6, and 18 months, often in the same preparation.
Since it began in the late 1980’s, the campaign to promote
HiB was accepted by nearly all pediatricians without a murmur,
and has in fact produced moderate reductions in the incidence
and severity of all systemic diseases involving this organism,70
including ear infections,71 which by then had become
an intractable problem in its own right. Yet this seemingly
glorious triumph for the vaccination concept has upstaged the
obvious risk of new, less friendly species occupying the vacancy
it left behind, or otherwise altering the normal ecological
balance of the pharynx as a whole, possibilities that do not
seem to bother or even have occurred to these experts. In addition
to its documented side effects, such as Guillain-BarrÈ syndrome,72
thrombocytopenic purpura,73 and invasive HiB disease
in the first two weeks after vaccination, associated with very
low levels of specific anti-body,74 this reckless
tampering with complex, well-established homeostatic mechanisms
to achieve limited, short-term goals gives ample grounds for
advocating a moratorium on HiB vaccination until more comprehensive
studies are carried out.
Hepatitis B
Introduced in the early 1990’s, the Hep B vaccine raises
a different set of issues. Widespread but only infrequently
fatal, Hepatitis B presents acutely, chronically, or both, and
occasionally leads to irreversible liver damage and cirrhosis,
which carry high risks of liver cancer and death. Transmitted
primarily through contaminated blood and to a lesser extent
by sexual contact, the disease has long been an important source
of ill health among IV drug users. In the 1980’s, the medical
system belatedly took notice when Hepatitis B and C, AIDS, and
other blood-borne diseases began to appear as contaminants in
donated blood, a scandal that pressured the blood banks into
more rigorous screening procedures.75
Because the clandestine subculture of IV drug use has always remained
beyond the reach of the medical system, campaigns of selective
Hep B vaccination aimed at these high-risk groups have never
been effective. In 1991 mandatory vaccination was finally introduced
as a last resort for exerting some degree of leverage over this
more and more intractable problem. The desperate and improbable
strategy adopted was to vaccinate all newborns in the hospital,
so that even those who become drug addicts in their teens and
twenties would be a littte less likely to get the disease, while
the blood supply would also be protected to that extent at least.
Sound far-fetched? Most pediatricians thought so, at least in
the beginning:
“I don’t see what the rush is,” said one pediatrician at a UCSF
conference, and neither did his audience. Only about a third
of the 400 attendees said they were giving the vaccine routinely
to infants. “We’re trying to prevent a disease 25-30 years from
now,” he added. Others felt that children receive too many vaccines
in the first year, that each injection is a disagreeable experience
which may adverse- ly affect compliance.76
Letters of protest began pouring in, many of them dubious that the
vaccine would last long enough to do any good, and predicting
that boosters would also be needed later:
The patient handout falsely assures parents that that the protective
effects will last throughout the child’s life, while the article
admits that antibody levels decline over time, and booster shots
may be needed. Since adolescence begins the period of greatest
exposure, immunizing them might be more effective, and compliance
would be higher.77
Nevertheless, most pediatricians remained strongly committed to vaccination
as a general strategy for fighting disease, and by the mid-1990’s
the majority were actively on board with the Hep B campaign
just as reports of adverse auto-immune reactions began to appear
in large numbers, and as usual it became their task to launder
and sanitize them.
Among the first of its kind, the Hep B vaccine is a product of bio-engineering,
a genetically recombinant form of the virus that is allegedly
no longer capable of replicating itself and to that extent no
longer “alive.” Ignoring the ultramicroscopic realm of epi-somes
and intracellular viral fragments, this purely semantic rationale
is widely invoked to defeat compensation claims for Hep B-related
auto-immune diseases, as I have said. While such facile word
games may have postponed another major scandal for a little
while longer, even the polite objections of ten years ago are
more than enough to predict a noisy failure for this hare-brained
scheme of vaccinating all newborns against a disease of young
adults that very few of them will ever come into contact with.
Rotavirus
While quickly smoothed over and all too easily forgotten,
this mini-disaster and the peculiar mentality that engendered
it should both be kept under glass as a specimen of what undoubtedly
lies ahead. In 1996, the AMA Journal published
a CDC report which advocated mass vaccination against rotavirus,
a major source of infectious diarrhea:
Rotavirus is the most common cause of severe diarrhea among
young children in the US. Of children up to five years old,
approximately 70% will become ill with rotavirus, of whom 1
in 8 will see a physician and 1 in 80 will be hospitalized.
Though it causes few deaths in this country, it causes 50,000
hospitalizations and $550 million in direct medical costs annually.
Safe live oral vaccines have been developed that will prevent
50-60% of the diarrhea and 70-100% of the severest cases. The
decision to implement a national vaccination program will be
based on the expected reduction in severe outcomes and its cost-effectiveness.
A previous study found it would yield net savings of $80 million
in health care costs and $465 million in social costs, based
on a price of $20 per dose.78
By their own math, however, the authors calculated a saving
of only $300 million in social costs and a net loss of
$100 million in health care costs that could only be offset
by lowering the price of the vaccine to the break-even point
of $9 per dose.79 Entitled “When Is Too Much Too
Much?” an editorial in the New England Journal of Medicine
took up the same issue and concluded that the program would
be extremely effective in the developing world, where rotavirus
and other infectious diarrheas pose an enormous and urgent public
health problem, but affordable and profitable only in affluent
countries like our own:
Diarrhea is no longer a serious threat in the United States. It remains
common, but its severity has diminished to about 300 deaths
per year. On the other hand, the vaccine is safe and can prevent
nearly half of all infections, 80% of the severe episodes, and
virtually all of the dehydration. An effective program of vaccination
would significantly reduce mortality, hospitalization, and other
medical costs, estimated at $500-600 million annually, as well
as the indirect costs, including lost wages for parents and
the cost of child care. When is too much too much? One hundred
preventable deaths per year are too many, and $500 million in
direct health care costs is too high. Hence a safe and effective
vaccine, even at $30 per dose, can be recommended for routine
use in the US and developed countries.80
Recommended by ACIP, the vaccine was mandated in
1998 for all infants, even though 5 cases of intussusception,
a life-threatening form of intestinal obstruction, had already
been reported in the trial population of 10,000 children, a
risk of about 0.05 per cent.81 In the first eight
months of the program, many new cases were discovered, and the
vaccine was quietly withdrawn pending further investigation,
which did establish “a strong, temporal, and specific causal
association” between the vaccine and this dangerous complication
that was much more prevalent than the trials had indicated.82
The vaccine was then hastily recalled and the whole affair
hushed up as if it had never happened.
For the moment I will leave aside the narrowness of the cost-benefit
calculation, which ignores the possibility of chronic, non-specific
effects like those I’ve described, and the fascinating process
by which vaccines are rubber-stamped for general use with at
most nominal regulation and oversight. The rotavirus vaccine
fiasco could not have happened without the zealous, crusading
attitude, usually left unstated but here made explicit, that
even the tiniest number of preventable deaths are unacceptable,
and that mass vaccination is always an appropriate strategy
to consider for eliminating them.
In a land so notoriously ruled by dollars and cents, these supremely
un-economical ideas both assume 1) that vaccination is inherently
safe, and indeed an unmixed blessing for the health of individuals
and nations alike, and 2) that whatever adverse effects an individual
vaccine or batch may have, there is never anything cumulative
about them, so that it is perfectly OK and indeed of great benefit
to pile on as many as we wish. Even in the absence of other
reasons, the enormous bulk of nonspecific reactions I have described
would be quite sufficient to prove both assumptions false. With
the new biotechnology companies now capable of manufacturing
vaccines against viruses and bacteria almost as fast as they
can identify them, the obvious un-wisdom of giving away our
public health and welfare to private, for-profit enterprises
is an issue that is already ubiquitous and becomes ever more
threatening with each new campaign.
Chickenpox
Many of the same issues are illustrated even more pointedly
in the history of the chickenpox or varicella vaccine, which
although first developed by Merck in the 1960’s, was never used
on a large scale until the Clinton years, when official enthusiasm
for all vaccination programs attained such dizzying heights
that a plausible rationale could at last be invented for marketing
it. Even then it was not an easy sell, since the chickenpox
is an illness so innocuous that the AMA Encyclopedia of Medicine
described it as “a common, mild infectious disease” to which
“all healthy children should be exposed at an age when it is
no more than an inconvenience.83 Even the American
Academy of Pediatrics, which yields to no one in its righteous
enthusiasm for vaccines, affirmed in a 1996 brochure that most
children who get chickenpox and are otherwise healthy 84
Bucking these traditional, common-sense attitudes, the manufacturers’
successful campaign to win a government mandate for universal
vaccination represents a brilliant coup for them and the industry,
clinched by exclusive “sweetheart” contracts with state health
departments and Federal agencies guaranteeing millions of doses
at their own chosen price. How did they pull it off?
Although nobody claimed that the disease was serious or even required
medical attention in most cases, the Clinton Administration’s
oft-repeated boasts about the cost-effectiveness of vaccination
as a favored health strategy enabled manufacturers to argue
that the huge savings in social costs, chiefly in lost wages
and extra day care, would make the vaccine a bargain for parents,
as alleged in this handout from the American Academy of Family
Physicians, designed to be distributed to parents as their kids
were offered up:
Why is a vaccine needed?
Chickenpox is usually a mild illness, but can cause problems like
brain swelling, pneumonia, and skin infections. It may be very
serious in infants and adults. Because it is so contagious,
children shouldn’t go to school or day care until all the sores
have dried or crusted. Many parents miss work during the illness,
because of which the lost pay can be a significant cost to them.85
As with Hep B, many physicians were lukewarm to the program
in the beginning, and compliance was very low. Here is a letter
from 1997, expressing the worries that have actually materialized
in the case of MMR, the waning immunity in adolescents and young
adults, associated with more severe illness and a higher risk
of complications:
Chickenpox has been a benign disease of preschool- and school-aged
children. Although immunization is supposedly axiomatic for
public health, vaccinating all kids against chickenpox is a
bad idea. It is unknown whether long-term immunity arises from
an attack of the disease, or from the virus repeatedly boosting
it in our communities, or how long immunity will last after
vaccination. Over time, mass vaccination will eradicate most
naturally occurring varicella and its booster effect. If the
immunity of vaccinated kids wanes with age, and unvaccinated
kids escape disease because contagion is rarer, life-threatening
outbreaks may occur as these kids grow older. Since morbidity
and mortality are increased in fetuses and after childhood,
an ever-expanding population of adults with unboosted or waning
immunity, including pregnant women, may be created.86
As expected, these hesitations and warnings were drowned out by special
pleading from the vaccination establishment. In a JAMA
editorial entitled “Just Do It!” two Yale pediatricians concluded
their pep talk with the following exhortation:
Do the benefits of universal immunization outweigh the risks?
Many studies show the risk of complications from varicella in
normal children, and there is evidence that they have been underestimated.
Others show that the vaccine is cost-effective. Why would we
deny children protection from this unpleasant rite of passage
when the evidence is so favorable? It’s time to stop procrastinating,
and JUST DO IT!87
Pneumococcus
Similar in many ways to HiB, the Pneumococcus vaccine
raises many of the same issues. A sometimes pathogenic strain
of Streptococci, the “pneumococcus,” or Strepto-cccus
pneumoniÊ, shares capsular polysaccharide antigens with
HÊmophilus influenzÊ, which are also the basis of its
virulence and the source of the vaccine. The organism also occupies
a similar niche in the normal flora of the pharynx and has been
implicated in the same diseases: otitis, sinusitis, pneumonia,
meningitis, and endocarditis.
Long before HiB, the pneumococcal vaccine was introduced during the
1970’s to prevent bacterial pneumonia in the elderly, especially
in overcrowded nursing homes and residential facilities, where
pneumococci were the species most frequently isolated. But the
vaccine proved only marginally effective in this already debilitated
population, as in this study of ambulatory but high-risk middle-aged
and elderly patients in the VA system:
We conducted a randomized, double-blind, placebo-controlled trial
to test the efficacy of a pneumococcal polysaccharide vaccine
in 2295 high-risk patients with one or more of the following:
age over 55, diabetes, alcoholism, chronic cardiac, pulmonary,
hepatic, or renal disease. We were unable to prove any efficacy
of the vaccine in preventing either pneumonia or bronchitis
in this population.88
As a result of such studies, the vaccine was not very popular
with either the target population or their doctors, who continued
to use it without much enthusiasm. So matters stood
until the Clinton years, when the war on childhood ear infections
reached its climax and the conventional strategy of aggressive
antibiotic treatment was exposed as a dismal failure. In the
late 1990’s, the vaccine was recycled for pediatric use when
it was found to be moderately effective in preventing otitis
media, in which the pneumococcus plays a major rÙle.89
Here at last was the marketing strategy that everyone had been
waiting for, and the vaccine is now being promoted aggressively,
not only for young children, but also for adolescents, young
adults, mature adults, and even middle-aged fifty-somethings
of the AARP set,90 as if it might eventually be refashioned
into a panacea for everyone and hopefully need to be repeated
throughout life.
Yet a sizeable number of pediatricians and other critics have continued
to resist this steamroller. In 2001 the Finnish Otitis Media
Study reported that a new vaccine was effective in preventing
ear infection, but several letters quickly punched gaping holes
in it:
The vaccine manufacturer concludes that the new vaccine is effective
for prevent- ion. But the data do not support this conclusion.
As the authors admit, the treated group could have had more
episodes than the controls. In 1999 these same data were presented
to the FDA, which rejected the use of this vaccine in otitis
media. But the most interesting results are ecological. In a
short time the predicted sero- type replacement, as observed
with other bacterial vaccines, was realized. With this clear
warning sign, it is ecologically perilous to push this vaccine.91
The most telling criticism came from a pediatrician in
Holland, where ear infect-ions are common but rarely medicated
or even considered a major public health problem:
According to the protocol, all infants received 4 vaccinations, which
led to the prevention of only 6% of cases. More could be gained
by changing our attitude toward acute otitis media, which
in the Netherlands is seen as a self-limiting dis- ease. Often
parents do not take their children to the doctor for it, and
antibiotics are only moderately effective anyway. As has been
shown, educating parents and doctors will lead to a decrease
in antibiotic prescriptions.92
Despite considerable evidence that it is ineffective and unsafe,
the pneumococcus vaccine continues to be promoted aggressively,
and I have no doubt that it will eventually be mandated, at
least for children, once these technical scruples are swept
aside.
Influenza
Prepared from live influenza viruses that are attenuated
in a medium of chick embryo cells, the influenza vaccine is
inactivated by formalin, split with hydrocarbon ethers into
antigenic fractions, and preserved with Thimerosal. Its unique
challenge and profitability lie in the fact that annual flu
epidemics involve different subtypes of the virus, which cannot
be known with certainty in advance, so that it has to be recreated
and marketed anew every year, before the epidemic, based
on extrapolation from possible animal reservoirs, i. e., on
guesswork, and is apt to be only partially effective,
despite some degree of cross-reactivity between various strains.
Like the pneumococcus, influenza vaccines were originally designed
to prevent pneumonia in the elderly, especially debilitated
patients in nursing homes and assisted living facilities. But
careful studies of this high-risk population yielded at best
mixed results and at times no results at all,93 while
serious adverse reactions, like the dreaded Guillain-BarrÈ polyneuritis,
were also reported with some frequency. In the 1978-79 season,
the highly-touted “swine flu” epidemic never materialized, but
over 40,000,000 people were given the vaccine, and several hundred
cases of severe polyneuritis were officially confirmed within
10 weeks of receiving it, representing a five- or six-fold increase
over its baseline prevalence in the unvaccinated,94
while unofficial reports suggested a rate much higher than that.
As ever, authoritative studies quickly appeared to discredit
any causal link, but a large volume of legal claims were settled
on the quiet by the manufacturer. The annual flu shot nevertheless
remained a popular ritual with many doctors and their elderly
patients and continues to be heavily promoted, but as with the
pneumococcus, the “hard sell” for mandating it had to wait until
the Clinton years, when vaccination came to be seen as the strategy
of last resort against health problems that seemed intractable
and unresponsive to other solutions, like otitis media, influenza
epidemics, and AIDS.
Building on the example of the chickenpox vaccine and its narrowly
economic rationale, the respected and influential American Academy
of Family Practice took the lead by recommending that annual
flu shots be offered to all adults aged 50 or older.95
In an interview with Family Practice News, Dr. H. F.
Young, AAFP Director of Scientific Affairs, emphasized the major
economic benefit of preventing absenteeism from work,96
while Dr. Gregory Poland of the National Coalition for Adult
Immunization cited the increased probability of complicating
risk factors like heart disease, asthma, emphysema, cancer,
and diabetes in this age group.97
The economic argument was soon recycled for vaccinating all
schoolchildren on a yearly basis, which a 1999 study claimed
would save hundreds of millions of dollars in lost wages and
eliminate the major reservoir of the disease.98 Facing
no real opposition, the same program was eventually extended
to healthy young adults in the work force,99 and
even to pregnant women, in order to protect their newborns from
the risk of RSV and bronchiolitis, according to one imaginative
CDC scientist.100 As with pneumococcus, the influenza
vaccine is clearly being groomed for mandatory use on a yearly
basis, with no recognition of even the possibility of a serious
downside to the idea.
Anthrax and Bioterrorism
Mandated for all U. S. military personnel serving in
the Middle East from the time of the first Gulf War in 1991,
the anthrax vaccine has been controversial from the start. First,
there was speculation“Gulf War syndrome,” an assortment of still
unexplained diseases reported by many veterans and downplayed
or covered up by officials of both Clinton and Bush Administrations.
As reported in the Boston Globe, this account
of one such veteran was typical of many:
Sgt. Frank Landry’s chest has been hurting a lot. He can’t
ride a bike, climb stairs, or play with his children. He wheezes
even with medication, sleeps propped up on three pillows, and
suffers from diarrhea and stomach pain. The worst of it is,
he doesn’t know what’s wrong. He left in perfect health two
years ago, to serve in the Gulf War as a specialist in nuclear,
chemical, and biological weapons, and he returned coughing up
phlegm and too short of breath to resume his job, as well as
dropping from 150 to 128 pounds,. Landry is one of many Gulf
War veterans who report a variety of mysterious ailments, such
as joint pain, hair loss, skin lesions, bleeding gums, asthma,
and digestive disturbances. They don’t know what causes them,
but Landry’s best guess is a reaction to the anthrax vaccine.
He’d never had lung problems before, and within an hour of receiving
it he began to wheeze, and felt as if his chest were filled
with water. He’s never been well since.
He can’t work, and accepts $1000 a month in food stamps and
Aid to Dependent Children, because he has two kids, his wife
has a bad back, and they’ve sold most of their possessions.
Meanwhile, the Government denies that his problems are service-related
and has reclassified him as fit for duty. Despite what happened,
he’s not bitter about the Army. He volunteered knowing the risks:
“they gave me a life and education. I was illiterate and got
my GED because I couldn’t be promoted without it.” No diagnosis
has been made. All he knows is that he can’t breathe, can’t
work, and can’t support his family. And he’s only 29 years old.101
A recent survey reported that more than 230,000 of the 600,000 troops
serving in the Gulf War have sought medical care, and that 185,000
have filed disability claims as a result of their ailments,
a shockingly high percentage, while almost 10,000 of them have
died, and no official explanation of their illnesses has ever
been offered.102
So matters stood until the late 1990’s, when in its enthusiasm for
vaccines the Clinton Administration required that all military
personnel receive the anthrax vaccine, whether on active duty
or not, and the vaunted discipline of the Armed Forces began
to crack. By 1999 several hundred officers and enlisted men
from all branches had accepted dishonorable discharges rather
than submit to the shots, as the Army reluctantly admitted in
a Boston Globe cover story:
In Maine, where he grew up, Zack Johnson didn’t have a reputation
for civil dis- obedience. He was so law-abiding and laid back
that his parents called him “Mr. Light ‘n’ Easy.” But the 22-year-old
Naval airman faces a court-martial because no threat of biological
weapons, or a jail sentence, or even of the loss of the GI Bill
he planned to use for college could persuade him to take the
anthrax vaccine. Ten Marines were court-martialed in California
last month for the same reason. An Army spokesperson says that
over 300,000 military personnel have had at least one shot,
and 175 to 200 people have refused, too few to affect battle-readiness.
But Mark Zaid, an attorney representing the 10 Marines, said,
“Some Air National Guard units have lost a third of their flight
crews and can’t be deployed any more.” He estimates the number
of refusals at 300 to 500.103
In a related story from the New York Times, the Surgeon-General
of the Army acknowledged the seriousness of the problem:
The happy military career of Jeffrey Bettendorf ended abruptly
Wednesday. A senior airman with an untarnished record, Bettendorf
was dishonorably dis charged for refusing to take the anthrax
vaccine, because he believed that the Pentagon had never proved
its safety or effectiveness. Facing rebellion from a growing
number of cases, the Pentagon dismissed them as insignificant,
but stopped counting how many had refused. “It speaks to an
undercurrent of distrust of the Government and the military,”
said Lt. General Ronald Blanck, Surgeon-General of the Army,
which oversees the anthrax program. “We have a credibility problem.”
The Marine Corps in particular has been hit hard. Resisters
note that there is no way to test the vaccine against the anthrax
used in weapons, and they criticize the lack of follow-up research
on those who did receive it during the Gulf War. They also point
to two FDA reports critical of the manufacturer, Michigan Biologic,
a state agency which was sold last year to Bioport, a private
company. One month later, Bioport was awarded a $29 million
contract to produce the vaccine for the Pentagon, which insists
that the program is safe and effective.
But reassurances are not enough for Marine Lance Cpl. Jason
Austin, who read that the vaccine can cause sterility and refused
to take it with four others in his antitank missile platoon
and now faces a court-martial. While their numbers are small,
they can upset the readiness of their units, notably in the
Reserve and National Guard, whose members can resign more easily
than those on active duty. In January, nine A-10 pilots with
the Connecticut Air National Guard, a quarter of the squadron,
quit rather than be vaccinated. At Travis AFB in California,
where Airman Bettendorf served, 11 of 40 reserve pilots in his
Squadron refused to take the vaccine, leaving them short-handed
just before heading to the Persian Gulf.104
As news of these refusals and disciplinary actions
spread, high-ranking officers began hearing the concerns of
the men and women under their command. Appointed Commander of
an F-16 Fighter Squadron, Lt. Colonel Thomas Heemstra, a decorated
combat veteran of 20 years’ experience, decided to investigate
the vaccine independently, and was outraged by what many personnel
had endured, including disrespect, ridicule, and inadequate
medical care. As told in his book, Col. Heemstra invited Dr.
Meryl Nass, a government consultant who had raised serious doubts
about the vaccine, to address his pilots.105 Including
firsthand accounts by three Michigan National Guardsmen who
were disabled by the vaccine and treated harshly by their superiors,
her lecture persuaded all twenty pilots who attended to refuse
the vaccine, as a result of which they were cashiered, including
the Colonel himself.106 The same fate befell Major
Sonnie Bates, another highly decorated combat pilot of long
experience who later testified before Congress on a wide variety
of auto-immune complaints observed in military personnel after
taking the shot.107
As the scandal spread through the ranks, investigators discovered
that many Gulf War syndrome patients who developed auto-immune
diseases after the anthrax vaccine showed antibodies to squalene,
a fat-soluble substance that was still being used by BioPort
as an experimental adjuvant in the vaccine, despite strong FDA
warnings in the past and solemn assurances by the Pentagon that
they had abandoned the practice.108 In part to counter
the bad press, Admiral William Crowe, ex-Chairman of the Joint
Chiefs of Staff, was named to BioPort’s Board of Directors and
given a 13% stake in the company in return for blessing the
anthrax venture.109 Ironically, he had previously
brokered the sale of weapons-grade anthrax to Saddam Hussein
by Donald Rumsfeld, President Reagan’s special emissary, for
later use against the Iranians and Kurds.110
Only a few weeks after the attacks of September 11, 2001, and the
official Bush Administration “Declaration of War” against Terrorism
worldwide, spores of weapons-grade anthrax made their way through
the Postal Service to the offices of Democratic Congressional
leaders and CBS Television News, resulting in 22 cases of cutaneous
and pulmonary anthrax and five deaths. Although the perpetrators
of these crimes have not been identified and the results of
an extensive Federal investigation have never been made public,
it leaked out that the material had been manufactured in the
U. S. Army Biological Warfare Laboratories, as the country trembled
with the realization that even such minute amounts were enough
to infect and kill people, and that the Government is essentially
powerless to stop a large-scale biological attack by a determined
enemy. These fears were assiduously cultivated by the Administration
to win support for the public health agenda of the Patriot Act
and the vast Homeland Security bureaucracy created to administer
it, but fantasies of vaccinating the general population brought
back the aftertaste of the military’s incestuous relationship
with BioPort and the ominous signs of its complicity in the
Gulf War syndrome, and the plan never got off the ground.
After September 11, the abortive campaign to vaccinate everyone
against smallpox was even more revealing. Amid the tragedy,
confusion, and heroism displayed at Ground Zero, the whole country
began taking seriously the possibility and indeed the likelihood
of nuclear, chemical, and biological attacks in the future.
Because anthrax cannot be trans-mitted from person to person,
each intended victim must be targeted individually and be brought
into direct physical contact with the spores, whose range is
therefore limited to the environs of a large city. Smallpox,
on the other hand, evokes deep mythic and historic fears of
plague and pestilence, because it is highly contagious and capable
of propagating itself to populations far beyond the target area,
so that many authorities entertained the idea of reintroducing
vaccinia, or cowpox, the original vaccine that had been used
for 200 years and had in fact eliminated smallpox from the world.
Yet when the Administration attempted to obtain large quantities
of it, and President Bush made a photo-op of rolling up his
own sleeve to receive it, the public remained surprisingly cool
to the idea. Even when a scaled-down plan was made optional
and offered to doctors, nurses, firemen, and other emergency
personnel, very few of them actually took it,111
and the predicted adverse reactions were widely publicized.112
Given the almost universal propensity to ignore or overlook
the adverse effects of vaccinating not only our children but
indeed everyone else against a host of other diseases both great
and small, this sudden show of solicitude and cold feet regarding
a vaccine that had seemed so familiar and effective is utterly
fascinating to me. How these same people can then resume taking
their annual flu shots and bringing in their babies for one
disease after another without a murmur has to rank with the
great unsolved mysteries of our time.
In any case, there is plenty of good sense in it, for it means
either that the actual threat of the vaccine is perceived to
be greater than the hypothetical threat of the disease, or that
the public simply does not believe that any vaccine can reliably
stop a determined enemy from doing us harm. In my view, both
reservations are well taken. Larry Brilliant, M. D., a veteran
epidemiologist formerly with WHO, said it better than anyone:
If Saddam has smallpox, he might use it if he were about to
be killed, but he also has the capacity to alter the virus to
make it vaccine-proof. Why would he use a virus that we have
a vaccine against? It makes no sense. If Al Qaeda has it, I
don’t believe they’d use it either. They want victory for a
people, a culture, a religion. Smallpox is the ultimate boomerang.
If released at Chicago-O’Hare, it’s only a matter of days before
it hits Mecca and Medina. It’s not a weapon for war unless one
seeks the destruction of both civilizations.113
Prof. David Rosner of Columbia gives another argument for the
same conclusion:
Smallpox is the only disease to have been eradicated through
human intervention. Yet we saw in it the chance to create a
new and better weapon of mass destruction. Both the U. S. and
Russia kept the virus in storage awaiting the opportunity to
terrorize the world. Both made it immune to the vaccine that
had eradicated it by genetically altering the virus. Even if
smallpox could be used as a weapon, the fear of it is being
used to make fundamental changes in public health. Mundane but
indispensable activities like making sure our water is safe
to drink, our air isn’t too polluted to breathe, and our food
isn’t too spoiled to eat are being sacrificed for fear of smallpox,
which plays into Bush’s strategy of militarizing public health.114
5. Implications for Health Policy
In conclusion, I will apply the broader, more comprehensive
viewpoint I have sketched out to identify some underlying themes
of our present vaccine policy, correct some of the inadequacies,
and resolve some of the contradictions and that follow from
them.